Therapeutic potential of green tea in nonalcoholic fatty liver disease.
about
Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver diseaseNon-alcoholic fatty liver disease: need for a balanced nutritional sourceVegetable consumption is linked to decreased visceral and liver fat and improved insulin resistance in overweight Latino youth.Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.Chemopreventive potential of green tea catechins in hepatocellular carcinoma.Chardonnay Grape Seed Flour Ameliorates Hepatic Steatosis and Insulin Resistance via Altered Hepatic Gene Expression for Oxidative Stress, Inflammation, and Lipid and Ceramide Synthesis in Diet-Induced Obese MiceGreen tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury.Dietary fructose feeding increases adipose methylglyoxal accumulation in rats in association with low expression and activity of glyoxalase-2Tea and flavonoids: where we are, where to go next.The role of antioxidants and other agents in alleviating hyperglycemia mediated oxidative stress and injury in liver.The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma.Green tea extract and the risk of drug-induced liver injury.The potential of flavonoids in the treatment of non-alcoholic fatty liver disease.Healthy properties of green and white teas: an update.Inhibition of pancreatic lipase by black tea theaflavins: Comparative enzymology and in silico modeling studies.Effect of Alkaloids from Nelumbinis Plumula against Insulin Resistance of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.(-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitisA dietary phytochemical blend prevents liver damage associated with adipose tissue mobilization in ovariectomized rats.Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients.Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.Epigallocatechin Gallate-Modified Graphite Paste Electrode for Simultaneous Detection of Redox-Active Biomolecules.Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease.A green tea-containing starch confection increases plasma catechins without protecting against postprandial impairments in vascular function in normoglycemic adults.Role of diet and nutritional management in non-alcoholic fatty liver disease.Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.The Aqueous Extract of Gynura divaricata (L.) DC. Improves Glucose and Lipid Metabolism and Ameliorates Type 2 Diabetes Mellitus.Exacerbation of liver steatosis following exposure to famine and overnutrition.Persimmon tannin accounts for hypolipidemic effects of persimmon through activating of AMPK and suppressing NF-κB activation and inflammatory responses in high-fat diet rats.Bioactive-rich Sideritis scardica tea (mountain tea) is as potent as Camellia sinensis tea at inducing cellular antioxidant defences and preventing oxidative stress.
P2860
Q26784396-B9795E1B-8274-4508-8523-17F31A0257D4Q28248994-D5206339-0B8B-410D-BE6C-1D53055D4B13Q34255695-9F8F5DB7-14A6-4B8D-8232-58109C8B1D97Q35127037-E09CC8DD-7960-4620-A5BD-DF36224DCCDDQ35381561-57B446D4-DD3F-4959-812F-EC9163F70054Q36224836-34604628-9525-4A85-91E8-F553B430BD0AQ36788693-25CB4BAD-3C30-4704-A8F6-9FFE48C420BDQ37061460-2D10DA24-DA91-4CD5-8616-6828620C9148Q37177436-4F6BA312-9628-489E-9C01-D6DB950CD353Q37318410-95771A39-97A9-4CA1-BFFD-EAC4414171EDQ38113967-B88EFDBB-E99B-47D0-B48E-69084D613D62Q38193582-F86E98F4-A8C1-4AEB-8216-98AACE6FB938Q38260305-626D60A7-2A1C-4F80-B50E-D193390E77BBQ38432731-3D4A0221-9D1F-45C6-A45D-3096C266D77CQ39390913-DB3872FE-C066-44C2-84AF-552B0E176C1FQ39421367-141C2BE7-E209-48A5-AEA4-309D5A2132FEQ41430210-FE7B76E2-40CD-4179-9F3F-0A2C7D1E91B0Q41446435-A5A3A49E-63B4-4B7F-B6FE-4BFC0CBC8DC2Q42469383-0B81A6E3-0031-42DC-9584-B273D7B364D8Q42669567-4F1200C6-5685-4921-9B80-73B1F4583CF6Q45031991-5CA1225A-00D2-4CB4-BCFE-8524C064139CQ47767188-324FD690-7941-423E-874A-8FD30ED5F8E9Q50194612-3CB3775C-1394-49BA-AE5C-5E047EBAF840Q50222263-7F0E4D6E-9AA7-43C3-BE28-FB3DEE9FB58EQ50468162-56C4AA05-7764-4AF2-8A70-434191816875Q50482649-042A6E64-FFE1-453A-9ED2-E66DFA67876FQ51243834-CF4C4F5F-4FD5-417D-A693-BBD150B8B068Q53740425-BD7B5092-B8F1-4385-85EF-8901DDAE6205Q54351676-C23AB828-7306-4152-946C-1F44E0BECD08Q55057172-D31918DA-1C78-4A92-947D-4574B138E0C0
P2860
Therapeutic potential of green tea in nonalcoholic fatty liver disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic potential of green tea in nonalcoholic fatty liver disease.
@en
Therapeutic potential of green tea in nonalcoholic fatty liver disease.
@nl
type
label
Therapeutic potential of green tea in nonalcoholic fatty liver disease.
@en
Therapeutic potential of green tea in nonalcoholic fatty liver disease.
@nl
prefLabel
Therapeutic potential of green tea in nonalcoholic fatty liver disease.
@en
Therapeutic potential of green tea in nonalcoholic fatty liver disease.
@nl
P2860
P1433
P1476
Therapeutic potential of green tea in nonalcoholic fatty liver disease
@en
P2093
Christopher Masterjohn
P2860
P356
10.1111/J.1753-4887.2011.00440.X
P577
2012-01-01T00:00:00Z